Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
European Radiology
Erschienen in: European Radiology 5/2017

29.08.2016 | Molecular Imaging

MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent

verfasst von: Annasofia Anemone, Lorena Consolino, Dario Livio Longo

Erschienen in: European Radiology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

X-ray iodinated contrast media have been shown to generate contrast in MR images when used with the chemical exchange saturation transfer (CEST) approach. The aim of this study is to compare contrast enhancement (CE) capabilities and perfusion estimates between radiographic molecules and a Gd-based contrast agent in two tumour murine models with different vascularization patterns.

Methods

MRI-CEST and MRI-CE T1w images were acquired in murine TS/A and 4 T1 breast tumours upon sequential i.v. injection of iodinated contrast media (iodixanol, iohexol, and iopamidol) and of gadoteridol. The signal enhancements observed in the two acquisition modalities were evaluated using Pearson’s correlation, and the correspondence in the spatial distribution was assessed by a voxelwise comparison.

Results

A significant, positive correlation was observed between iodinated contrast media and gadoteridol for tumour contrast enhancement and perfusion values for both tumour models (r = 0.51-0.62). High spatial correlations were observed in perfusion maps between iodinated molecules and gadoteridol (r = 0.68-0.86). Tumour parametric maps derived by iodinated contrast media and gadoteridol showed high spatial similarities.

Conclusions

A good to strong spatial correlation between tumour perfusion parameters derived from MRI-CEST and MRI-CE modalities indicates that the two procedures provide similar information.

Key Points

• Gd-based agents are the standard of reference for contrast-enhanced MRI.
• Iodinated contrast media provides MRI-CEST contrast enhancement in animal tumour models.
• Contrast enhancements were positively correlated between iodinated agents and gadoteridol.
• Tumour perfusion map showed similar spatial distribution between iodinated agents and gadoteridol.
• MRI-CEST with iodinated agents provide similar information to gadoteridol.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Hylton N (2006) Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 24:3293–3298CrossRefPubMed
2.
3.
4.
Winfield JM, Payne GS, deSouza NM (2015) Functional MRI and CT biomarkers in oncology. Eur J Nucl Med Mol Imaging 42:562–578CrossRefPubMed
5.
Morana G, Cugini C, Scatto G, Zanato R, Fusaro M, Dorigo A (2013) Use of contrast agents in oncological imaging: magnetic resonance imaging. Cancer Imaging 13:350–359CrossRefPubMedPubMedCentral
6.
7.
Grobner T (2006) Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21:1104–1108CrossRefPubMed
8.
Yang L, Krefting I, Gorovets A et al (2012) Nephrogenic systemic fibrosis and class labeling of gadolinium-based contrast agents by the Food and Drug Administration. Radiology 265:248–253CrossRefPubMed
9.
Thomsen HS, Morcos SK, Almen T et al (2013) Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 23:307–318CrossRefPubMed
10.
Idee JM, Fretellier N, Robic C, Corot C (2014) The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update. Crit Rev Toxicol 44:895–913CrossRefPubMed
11.
Aime S, Caravan P (2009) Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J Magn Reson Imaging 30:1259–1267CrossRefPubMedPubMedCentral
12.
Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D (2014) High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270:834–841CrossRefPubMed
13.
Quattrocchi CC, Mallio CA, Errante Y et al (2015) Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy. Investig Radiol 50:470–472CrossRef
14.
Radbruch A, Weberling LD, Kieslich PJ et al (2015) Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 275:783–791CrossRefPubMed
15.
Halvorsen RA (2008) Which study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR Imaging. Radiology 249:9–15CrossRefPubMed
16.
Dawson P, Blomley MJK (1996) Contrast media as extracellular fluid space markers: Adaptation of the central volume theorem. Br J Radiol 69:717–722CrossRefPubMed
17.
18.
Vinogradov E, Sherry AD, Lenkinski RE (2013) CEST: from basic principles to applications, challenges and opportunities. J Magn Reson 229:155–172CrossRefPubMed
19.
20.
Castelli DD, Terreno E, Longo D, Aime S (2013) Nanoparticle-based chemical exchange saturation transfer (CEST) agents. NMR Biomed 26:839–849CrossRefPubMed
21.
Terreno E, Castelli DD, Aime S (2010) Encoding the frequency dependence in MRI contrast media: the emerging class of CEST agents. Contrast Media Mol Imaging 5:78–98PubMed
22.
Longo DL, Dastru W, Digilio G et al (2011) Iopamidol as a responsive MRI-chemical exchange saturation transfer contrast agent for pH mapping of kidneys: In vivo studies in mice at 7 T. Magn Reson Med 65:202–211CrossRefPubMed
23.
Aime S, Calabi L, Biondi L et al (2005) Iopamidol: Exploring the potential use of a well-established x-ray contrast agent for MRI. Magn Reson Med 53:830–834CrossRefPubMed
24.
Müller-Lutz A, Khalil N, Schmitt B et al (2014) Pilot study of Iopamidol-based quantitative pH imaging on a clinical 3T MR scanner. MAGMA
25.
Longo DL, Michelotti F, Consolino L et al (2016) In Vitro and in vivo assessment of nonionic iodinated radiographic molecules as chemical exchange saturation transfer magnetic resonance imaging tumor perfusion agents. Invest Radiol 51:155–162
26.
Chen SZ, Yuan J, Deng M, Wei J, Zhou J, Wang YJ (2016) Chemical exchange saturation transfer (CEST) MR technique for in-vivo liver imaging at 3.0 tesla. Eur Radiol 26:1792–800
27.
28.
Jiang S, Yu H, Wang X et al (2016) Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla. Eur Radiol 26:64–71CrossRefPubMed
29.
Zaiss M, Windschuh J, Goerke S et al (2016) Downfield-NOE-suppressed amide-CEST-MRI at 7 Tesla provides a unique contrast in human glioblastoma. Magn Reson Med
30.
Donahue MJ, Donahue PC, Rane S et al (2016) Assessment of lymphatic impairment and interstitial protein accumulation in patients with breast cancer treatment-related lymphedema using CEST MRI. Magn Reson Med 75:345–355CrossRefPubMed
31.
Cai K, Singh A, Poptani H et al (2015) CEST signal at 2ppm (CEST@2ppm) from Z-spectral fitting correlates with creatine distribution in brain tumor. NMR Biomed 28:1–8PubMed
32.
Longo DL, Busato A, Lanzardo S, Antico F, Aime S (2013) Imaging the pH evolution of an acute kidney injury model by means of iopamidol, a MRI-CEST pH-responsive contrast agent. Magn Reson Med 70:859–864CrossRefPubMed
33.
Chen LQ, Howison CM, Jeffery JJ, Robey IF, Kuo PH, Pagel MD (2014) Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI. Magn Reson Med 72:1408–1417
34.
Longo DL, Sun PZ, Consolino L, Michelotti FC, Uggeri F, Aime S (2014) A general MRI-CEST ratiometric approach for pH imaging: demonstration of in vivo pH mapping with lobitridol. J Am Chem Soc 136:14333–14336CrossRefPubMedPubMedCentral
35.
Chen LQ, Randtke EA, Jones KM, Moon BF, Howison CM, Pagel MD (2015) Evaluations of tumor acidosis within in vivo tumor models using parametric maps generated with AcidoCEST MRI. Mol Imaging Biol 17:488–96
36.
Jones KM, Randtke EA, Howison CM et al (2015) Measuring extracellular pH in a lung fibrosis model with acidoCEST MRI. Mol Imaging Biol 17:177–184CrossRefPubMedPubMedCentral
37.
Terreno E, Stancanello J, Longo D et al (2009) Methods for an improved detection of the MRI-CEST effect. Contrast Media Mol Imaging 4:237–247CrossRefPubMed
38.
Lavini C, Verhoeff JJ, Majoie CB, Stalpers LJ, Richel DJ, Maas M (2011) Model-based, semiquantitative and time intensity curve shape analysis of dynamic contrast-enhanced MRI: a comparison in patients undergoing antiangiogenic treatment for recurrent glioma. J Magn Reson Imaging 34:1303–1312CrossRefPubMed
39.
Holden G (1993) Statistical power analysis for the behavioral-sciences, 2nd edition - cohen. J Soc Work Health Care 18:131–132
40.
Iagaru A, Gambhir SS (2013) Imaging tumor angiogenesis: the road to clinical utility. AJR Am J Roentgenol 201:W183–W191CrossRefPubMed
41.
Brix G, Griebel J, Kiessling F, Wenz F (2010) Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements. Eur J Nucl Med Mol Imaging 37:S30–S51CrossRefPubMed
42.
Kim JH, Kim HJ, Lee KH, Kim KH, Lee HL (2004) Solitary pulmonary nodules: a comparative study evaluated with contrast-enhanced dynamic MR imaging and CT. J Comput Assist Tomogr 28:766–775CrossRefPubMed
43.
Kierkels RG, Backes WH, Janssen MH et al (2010) Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer. Int J Radiat Oncol Biol Phys 77:400–408CrossRefPubMed
44.
Xu X, Yadav NN, Knutsson L et al (2015) Dynamic glucose-enhanced (DGE) MRI: translation to human scanning and first results in glioma patients. Tomography 1:105–114CrossRefPubMedPubMedCentral
45.
Xu X, Chan KW, Knutsson L et al (2015) Dynamic glucose enhanced (DGE) MRI for combined imaging of blood-brain barrier break down and increased blood volume in brain cancer. Magn Reson Med 74:1556–1563CrossRefPubMedPubMedCentral
46.
Murakami M, Ernsting MJ, Undzys E, Holwell N, Foltz WD, Li SD (2013) Docetaxel conjugate nanoparticles that target alpha-smooth muscle actin-expressing stromal cells suppress breast cancer metastasis. Cancer Res 73:4862–4871CrossRefPubMed
47.
Yankeelov TE, DeBusk LM, Billheimer DD et al (2006) Repeatability of a reference region model for analysis of murine DCE-MRI data at 7T. J Magn Reson Imaging 24:1140–1147CrossRefPubMed
48.
Rutten A, Prokop M (2007) Contrast agents in X-ray computed tomography and its applications in oncology. Anticancer Agents Med Chem 7:307–316CrossRefPubMed
49.
Aime S, Botta M, Terreno E (2005) Gd(III)-based contrast agents for MRI. Adv Inorg Chem - Incl Bioinorg Stud 57:173–237CrossRef
50.
Laurent S, Elst LV, Muller RN (2006) Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents. Contrast Media Mol Imaging 1:128–137CrossRefPubMed
Metadaten
Titel
MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent
verfasst von
Annasofia Anemone
Lorena Consolino
Dario Livio Longo
Publikationsdatum
29.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2017
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4552-7

Weitere Artikel der Ausgabe 5/2017

European Radiology 5/2017 Zur Ausgabe

Breast

Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values

Experimental

Abdominal aortic aneurysm follow-up by shear wave elasticity imaging after endovascular repair in a canine model

Magnetic Resonance

Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate

Urogenital

Assessment of deep myometrial invasion of endometrial cancer on MRI: added value of second-opinion interpretations by radiologists subspecialized in gynaecologic oncology

Hepatobiliary-Pancreas

Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis

Emergency Radiology

Imaging algorithms and CT protocols in trauma patients: survey of Swiss emergency centers

Neu im Fachgebiet Radiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise